Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Somnigroup International Inc. released an updated investor presentation on November 9, 2026, highlighting its vertically integrated strategy as a global bedding company. The presentation outlines the company's omnichannel reach, global manufacturing footprint, and its position to capitalize on a projected $120 billion global bedding market recovery.
The Marygold Companies reported financial results for its first fiscal quarter ended September 30, 2026, with revenue increasing to $9.4 million from $5.2 million in the prior year. The company swung to a net income of $1.8 million ($0.04 per share) compared to a net loss of $0.4 million a year ago, driven largely by strong growth at its USCF Investments subsidiary. Management also highlighted the pending acquisition of the company by Madison Dearborn Partners for $2.00 per share, expected to close in the first half of 2027.
Term
Q1 2027
“During the quarter, the Company announced it had entered into a definitive merger agreement under which funds managed by Madison Dearborn Partners will acquire all of the outstanding shares of The Marygold Companies for $2.00 per share, representing a premium of 100% over the Company’s closing share price on September 24, 2026, the day before the agreement was announced. The transaction is expected to close during the first half of 2027, or earlier, upon satisfaction of a number of closing conditions that are usual and customary for transactions of this nature.”
Nicholas Gerber, Chief Executive Officer
“Revenues and income increased significantly for the first quarter, primarily reflecting the increased activity in energy related ETFs, due in part to the Iran war. Our other non-financial services operations, including discontinued operations in New Zealand, were also profitable during the first quarter. However, our UK investment advisory businesses recorded a net loss of $0.1 million for the quarter as compared with a net loss of $0.4 million for the prior year quarter, showing a significant reduction in expenses associated with the mobile fintech banking app now on pause.”
California Resources President and CEO Francisco Leon Buys $37.3K of Stock
Francisco Leon, President and CEO, bought 800 shares of California Resources Corp at $46.63 a share, worth $37.3K in total on Nov 6, 2026. Shares held after the trade: 333,177 (+0.2%).
Inflection Point Acquisition Corp. VI M&A Deal with Quantum Space, LLC
Inflection Point Acquisition Corp. VI provided a status update on its pending merger with Quantum Space, LLC, announcing a Virtual Analyst Day to discuss the company's technology platform and mission pipeline. Upon completion of the business combination, the combined company is expected to list on the NYSE under the ticker symbol QSPC.
Veradermics announced positive 12-month topline results from Part B of its Phase 2/3 Study '302' evaluating VDPHL01 for male pattern hair loss. The data showed significant increases in non-vellus hair counts and high rates of patient-reported visible improvement with no new safety signals. These results support a potential FDA submission for the first non-hormonal oral treatment for pattern hair loss in nearly 30 years.
Delcath Systems reported a significant increase in product revenue to $89.2 million for the first nine months of 2026, resulting in a net income of $8.6 million compared to $4.6 million in the prior year. The company maintained a strong liquidity position with $104.3 million in cash and short-term investments as of September 30, 2026.
KALA BIO announced preliminary unaudited financial results for the third quarter of 2026, reporting a significantly reduced net loss of $0.8 million compared to $7.6 million in the prior year. The company ended the period with $7.0 million in cash and no debt as it continues its strategic shift toward building an AI infrastructure platform for the biotechnology industry.
AiXin Life International reported a total revenue of $211,527 for the three months ended March 31, 2026, a significant decrease from $398,831 in the prior year period. The company incurred a net loss of $531,728 and continues to operate with a substantial stockholders' deficit of over $7.1 million.
Telos Corporation reported its third quarter 2026 financial results for the period ended September 30, 2026. The company hosted a conference call and webcast to discuss the results and provided supplemental presentation materials on its investor relations website.
United-Guardian reported strong third quarter 2026 results with net sales increasing 54% to $3.5 million and net income surging 247% to $0.93 million. Growth was driven by a 187% increase in cosmetic ingredient sales and a 29% rise in pharmaceutical sales, specifically for its lead product Renacidin.
Term
Q3 2026
“I am very excited to report that our third quarter was exceptionally strong, with pharmaceuticals, personal care and medical lubricants all posting sales increases. Pharmaceutical sales grew 29% compared with the same period in 2025, driven primarily by Renacidin®, our most important pharmaceutical product.”
Donna Vigilante, President of United-Guardian
“I am very pleased with our performance for the first nine months of 2026. Our growth initiatives have produced encouraging results, and we plan to continue building on this progress.”
Century Communities appointed James Francescon as President, effective January 1, 2027, as part of a long-term succession plan. His compensation package includes a $750,000 base salary, a 200% target bonus opportunity, and a promotional grant of 35,008 restricted stock units. Robert J. Francescon will transition from Co-Principal Executive Officer to sole Principal Executive Officer while remaining CEO.
Southern EVP & CLO Sterling A. Spainhour Jr. Sells $306K of Stock
Sterling A. Spainhour Jr., EVP & CLO, sold 3,333 shares of Southern Co at $91.81 a share, worth $306K in total on Nov 6, 2026. Shares held after the trade: 31,886 (-9.5%).
Village Farms delivered record cannabis revenues of $55 million and 27% adjusted EBITDA margins, driven by 75% international growth despite significant price compression in the Canadian wholesale trim market.
SM Energy Company appointed George Green as Senior Vice President – Chief Legal Officer and Corporate Secretary, effective November 9, 2026. Mr. Green previously served as General Counsel of PerkinElmer and Group Vice President and General Counsel at DCP Midstream. In connection with the appointment, James Lebeck will transition from his role as General Counsel to continue serving as Executive Vice President – Chief Corporate Development Officer.
Capstone Holding Corp. entered into an amendment with 3i, LP to extend the maturity date of its senior secured convertible note from October 2026 to December 13, 2027. The company has retired approximately 87% of its original convertible debt, leaving $0.9 million in principal outstanding. Additionally, the company extended the term of its common stock purchase agreement with Tumim Stone Capital, LLC to January 2028.
Coursera's Board of Directors adopted a limited-duration stockholder rights plan (poison pill) in response to a third-party stockholder accumulating a 14.7% stake. The plan triggers if any person or group acquires 15% or more of the company's common stock, allowing other stockholders to purchase shares at a 50% discount to protect against a hostile takeover or creeping control.
Axogen, Inc. filed a corporate presentation and hosted an investor event on November 9, 2026, to announce its decision to move forward with a commercial market launch for prostate nerve reconstruction. The presentation highlights the clinical need and market opportunity for using Avance Nerve Allograft to restore erectile function and quality of life following robotic-assisted radical prostatectomies.
Warner Music Group Corp. declared a regular quarterly cash dividend of $0.20 per share on its Class A and Class B common stock. The dividend is payable on December 1, 2026, to stockholders of record as of November 20, 2026.
Heron Therapeutics filed its 10-Q for the period ended September 30, 2026, reporting 190,273,587 shares of common stock outstanding. The filing highlights a pending Asset Sale to CorMedix and notes significant risks regarding the company's ability to continue as a going concern without additional funding.
Faeth Therapeutics announced topline clinical data from its Phase 2 PIK-201 trial evaluating its product candidate PIKTOR in patients with advanced endometrial cancer. The trial evaluated PIKTOR (a combination of serabelisib and sapanisertib) in combination with paclitaxel. The company released a corporate presentation detailing these preliminary efficacy and safety results to investors.
Bitmine Immersion Technologies disclosed its current treasury holdings, reporting total crypto, cash, and marketable securities of $14.3 billion. The company now holds 6.07 million ETH tokens, representing 4.97% of the total ETH supply, and reaffirmed its strategy of weekly ETH accumulation.
ContextLogic Holdings Inc. reported a net loss of $13.4 million for the three months ended September 30, 2026, compared to a net income of $3.0 million in the prior year period. The company underwent a significant transition from a Predecessor to a Successor entity in February 2026, marked by substantial acquisitions and a rights offering that increased total assets to $964.9 million.
Innovative Industrial Properties amended its existing at-the-market (ATM) offering program to add its 9.25% Series B Cumulative Redeemable Preferred Stock to the facility. The program allows for the sale of common and preferred shares with an aggregate offering price of up to $500 million, of which approximately $336.9 million remains available for future issuance.
SS&C Technologies Holdings $1.2B Debt Financing with Wilmington Trust, National Association
SS&C Technologies completed an upsized private offering of $1.2 billion in 2.75% Convertible Senior Notes due 2031, which includes the full exercise of a $150 million overallotment option. The proceeds are intended to fund capped call transactions, repurchase up to $100 million in common stock, and refinance the company's existing 5.500% Senior Notes due 2027.
Mereo BioPharma reported a net loss of $19.6 million for the nine months ended September 30, 2026, an improvement from the $34.5 million loss in the prior year period. Cash and cash equivalents decreased to $26.1 million from $41.0 million at the end of 2025, primarily driven by research and development expenses for its rare disease clinical programs.
Quanterix Corp reported total revenues of $104.3 million for the nine months ended September 30, 2026, a 10% increase year-over-year, though it recorded a net loss of $88.1 million. The company's financial position was impacted by $46.9 million in impairment and restructuring costs and a significant decrease in marketable securities from $88.4 million to $41.5 million since the end of 2025.
R. Howard Coker will retire as President and CEO of Sonoco effective December 31, 2026, after a 41-year career with the company. Ernest D. Haynes III, currently President of Global Consumer Packaging, has been appointed to succeed him as President, CEO, and a director. The transition includes a $1.1 million base salary for Haynes and a $1.5 million retention RSU award for CFO Paul Joachimczyk.
Fervo Energy reported Q3 2026 financial results, highlighting the achievement of commercial operation at its 33-megawatt Cape Station Phase I GeoBlock 1. The company also signed a major 396-megawatt power purchase agreement with Google, with an option to expand the partnership to nearly 1 gigawatt.
“In the third quarter, Cape Station achieved a major milestone, reaching first power and contractual commercial operation. We also signed what we believe is the largest enhanced geothermal power purchase agreement to date with Google, creating a pathway to scaling our partnership to nearly a gigawatt.”
ContextLogic Holdings Inc. reported Q3 2026 revenue of $32.2 million, which was flat year-over-year as higher average sales prices were offset by a 5.7% decrease in volume due to trucking availability constraints. The company reported a net loss of $13.4 million, driven by corporate platform costs and increased amortization following its acquisition of US Salt earlier in the year.
Term
Q3 2026
“Shipments this quarter were again constrained by limited trucking availability, and we are working to address this directly and proactively. We have numerous initiatives in flight to improve outbound freight, including a drop and hook program, and we are beginning to see early signs of progress.”
Aptevo Therapeutics presented new preclinical data for its multispecific platform candidates APVO451, APVO452, and APVO711 at the SITC 2026 Annual Meeting. The data demonstrated the molecules' ability to activate immune pathways and promote tumor-cell killing even under immunosuppressive conditions typical of solid tumors. These findings support the continued development of the company's portfolio of CD40-stimulating cancer immunotherapies.